Search research articles
Contact Us
Filters
Showing results (171-180 of 199) with videos related to
Page
of 20
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
December 12, 2019
Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resection
Ding-Hui Dong, Xu-Feng Zhang, Alexandra G Lopez-Aguiar, et al.
The Journal of Surgical Research
|
January 30, 2019
Evidence Versus Practice in Early Drain Removal After Pancreatectomy
Nicole Villafane-Ferriol, Katherine A Baugh, Amy L McElhany, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
January 18, 2024
Intracystic injection of large surface area microparticle paclitaxel for chemoablation of intraductal papillary mucinous neoplasms: Insights from an expanded access protocol
Somashekar G Krishna, Devarshi R Ardeshna, Zarine K Shah, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 19, 2018
Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms
Jeffery Chakedis, Eliza W Beal, Alexandra G Lopez-Aguiar, et al.
Annals of Surgical Oncology
|
November 26, 2022
Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors
Eleftherios A Makris, John G Douglas Cannon, Jeffrey A Norton, et al.
Annals of Surgery
|
July 9, 2019
A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients
Mohammad Y Zaidi, Alexandra G Lopez-Aguiar, Jeffrey M Switchenko, et al.
Journal of Surgical Oncology
|
February 16, 2018
Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group
Katiuscha Merath, Fabio Bagante, Eliza W Beal, et al.
Surgery
|
October 4, 2018
Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group
Xu-Feng Zhang, Zheng Wu, Jordan Cloyd, et al.
The American Surgeon
|
January 8, 2020
Evaluating the ACS-NSQIP Risk Calculator in Primary GI Neuroendocrine Tumor: Results from the United States Neuroendocrine Tumor Study Group
Emily A Armstrong, Eliza W Beal, Alexandra G Lopez-Aguiar, et al.
Gastrointestinal Endoscopy
|
November 18, 2024
Interobserver agreement in dysplasia grading of intraductal papillary mucinous neoplasms: performance of Kyoto guidelines and optimization of endomicroscopy biomarkers through pathology reclassification
Matthew Leupold, Wei Chen, Ashwini K Esnakula, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 199) with videos related to
Sort By:
Page
of 20
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
December 12, 2019
Tumor burden score predicts tumor recurrence of non-functional pancreatic neuroendocrine tumors after curative resection
Ding-Hui Dong, Xu-Feng Zhang, Alexandra G Lopez-Aguiar, et al.
The Journal of Surgical Research
|
January 30, 2019
Evidence Versus Practice in Early Drain Removal After Pancreatectomy
Nicole Villafane-Ferriol, Katherine A Baugh, Amy L McElhany, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
January 18, 2024
Intracystic injection of large surface area microparticle paclitaxel for chemoablation of intraductal papillary mucinous neoplasms: Insights from an expanded access protocol
Somashekar G Krishna, Devarshi R Ardeshna, Zarine K Shah, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 19, 2018
Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms
Jeffery Chakedis, Eliza W Beal, Alexandra G Lopez-Aguiar, et al.
Annals of Surgical Oncology
|
November 26, 2022
Calcifications and Cystic Morphology on Preoperative Imaging Predict Survival After Resection of Pancreatic Neuroendocrine Tumors
Eleftherios A Makris, John G Douglas Cannon, Jeffrey A Norton, et al.
Annals of Surgery
|
July 9, 2019
A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients
Mohammad Y Zaidi, Alexandra G Lopez-Aguiar, Jeffrey M Switchenko, et al.
Journal of Surgical Oncology
|
February 16, 2018
Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group
Katiuscha Merath, Fabio Bagante, Eliza W Beal, et al.
Surgery
|
October 4, 2018
Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group
Xu-Feng Zhang, Zheng Wu, Jordan Cloyd, et al.
The American Surgeon
|
January 8, 2020
Evaluating the ACS-NSQIP Risk Calculator in Primary GI Neuroendocrine Tumor: Results from the United States Neuroendocrine Tumor Study Group
Emily A Armstrong, Eliza W Beal, Alexandra G Lopez-Aguiar, et al.
Gastrointestinal Endoscopy
|
November 18, 2024
Interobserver agreement in dysplasia grading of intraductal papillary mucinous neoplasms: performance of Kyoto guidelines and optimization of endomicroscopy biomarkers through pathology reclassification
Matthew Leupold, Wei Chen, Ashwini K Esnakula, et al.
Page
of 20